Adjunct Photodynamic Therapy in Chronic Periodontitis Among Cigarette-smokers.
Effectiveness of Scaling and Root Planing With and Without Adjunct Antimicrobial Photodynamic Therapy in the Treatment of Chronic Periodontitis Among Cigarette-smokers and Never-smokers: A Randomized Controlled Clinical Trial
1 other identifier
interventional
83
0 countries
N/A
Brief Summary
This study evaluates the efficacy of scaling and root planing with and without adjunct antimicrobial photodynamic therapy (aPDT) in the treatment of chronic periodontitis (CP) among cigarette-smokers and never-smokers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 2, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2017
CompletedFirst Submitted
Initial submission to the registry
October 3, 2017
CompletedFirst Posted
Study publicly available on registry
October 12, 2017
CompletedOctober 12, 2017
October 1, 2017
1.4 years
October 3, 2017
October 6, 2017
Conditions
Outcome Measures
Primary Outcomes (2)
Probing depth
Probing depth will be measured as the distance from the gingival margin to the location of the tip of the probe to the nearest millimeter. Pocket depth assessment was carried out at 6 sites per tooth for all teeth (disto-buccal, mid-buccal, mesio-buccal, mesio-lingual, mid-lingual and disto-lingual)
3 months
Clinical attachment level gain
Clinical attachment level gain will be calculated for each site as the sum of probing depth and gingival recession. The CAL was recorded at 6 sites per tooth for all teeth (disto-buccal, mid-buccal, mesio-buccal, mesio-lingual, mid-lingual and disto-lingual) except third molars.
3 months
Secondary Outcomes (2)
Plaque index
3 months
Bleeding on probing
3 months
Study Arms (2)
Adjunctive photodynamic therapy
EXPERIMENTALThis arm will be given scaling and root planing (SRP) with adjunctive photodynamic therapy (aPDT)
Dental scaling
ACTIVE COMPARATORThis arm will be given scaling and root planing (SRP) only
Interventions
In groups 1 and 2, aPDT was performed after SRP. The protocol for aPDT is described elsewhere. Briefly, using a blunt needle, 0.005% of Methylene blue was applied into the periodontal pocket and left in place for 10 seconds. The dye was then irradiated with a diode laser (670 nanometers) at 150 milliwatts. In each dye filled periodontal pocket, laser irradiation was performed for one minute using a flexible tip. In the present study, aPDT was performed once, at baseline, by a trained dentist.
In both groups, SRP was performed in one session under local anesthesia using handheld Gracey curettes No. 5/6. One trained dental hygienist blinded to the study groups and subgroups made 9 to 10 strokes in a vertical (apico-coronal) direction and the inclination between scaler tips and roots was maintained as zero. When the curved explorer indicated a smooth and hard dental surface, SRP was judged as completed. In all individuals, SRP was done in one session without any assigned time limit for completion.
Eligibility Criteria
You may qualify if:
- Self-reported habitual cigarette-smokers.
- Self-reported never-smokers.
- Patients with chronic periodontitis (presence of at least 30% sites with ≥ 3 mm of CAL and PD ≥ 3 mm.
You may not qualify if:
- Patients with systemic diseases such as acquired immune deficiency syndrome/HIV and diabetes mellitus.
- Habitual smokeless tobacco product and alcohol users.
- Third molars and fractured teeth with embedded root remnants and edentulous individuals.
- Patients with misaligned teeth.
- Patients that reported to have used antibiotics, non-steroidal anti-inflammatory drugs and/or steroids within the past 90 days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Clinical Research
Study Record Dates
First Submitted
October 3, 2017
First Posted
October 12, 2017
Study Start
February 16, 2016
Primary Completion
July 2, 2017
Study Completion
September 16, 2017
Last Updated
October 12, 2017
Record last verified: 2017-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Data is available
De-identified individual participant data for all primary outcome measures will be made available